by Richard C. Boldt
The allocation of treatment resources in the behavioral health system in the United States has shifted dramatically over the past fifty years.
10 Drexel L. Review 1
by Vanita Saleema Snow
This article seeks to reignite the conversation about discriminatory
policing and how racially biased policing results in law enforcement
disproportionately seizing African Americans’ property suspected of
being related to illegal activity. But, it also attempts to situate issues
of protest movements as a vehicle to move the Supreme Court to
change discriminatory standards under forfeiture statutes.
10 Drexel L. Review 69
by Gabrielle Goldstein
This
Article identifies and describes the development of four areas of
regulatory oversight: (1) human subjects research, (2) animal
research, (3) scientific integrity and misconduct, and (4) financial
conflicts of interest. Each is an example of management-based
regulation: regulated entities have flexibility in designing policies and
programs that meet generalized regulatory requirements.
10 Drexel L. Review 127
by Sonia Weil
This Article explores the harms the industrialized agricultural industry creates and the legal protections the industry enjoys in environmental law, animal cruelty law, labor law, anti-terrorism law, and through heightened protections in trespass and libel law.
10 Drexel L. Review 183
by Ryan J. Silver
It is imperative that the United States shift to a multi-party
system, and that states enact laws to adopt single transferable vote/
instant runoff voting systems. These voting systems allow voters the
opportunity to rank candidates, with their vote automatically going to
the candidate who stands the best chance of winning. Only then will
the United States have a truly representative democracy, increased
voter turnout, and guaranteed fundamental rights for voters.
10 Drexel L. Review 239
by Brittany Stepp
In addition to implementing pending legislation, Congress should look
to the European Union (EU) laws and adopt additional safeguards.
Similar to the EU, it is essential that the FDA be granted authority to
reevaluate and update permissible ingredients on a rolling basis.
10 Drexel L. Review 277